186 related articles for article (PubMed ID: 14704816)
21. [Immunosuppression for kidney transplant recipients: current strategies].
Alberú J; Urrea EM
Rev Invest Clin; 2005; 57(2):213-24. PubMed ID: 16524061
[TBL] [Abstract][Full Text] [Related]
22. Long-term impact of discontinued or reduced calcineurin inhibitor in patients with chronic allograft nephropathy.
Weir MR; Ward MT; Blahut SA; Klassen DK; Cangro CB; Bartlett ST; Fink JC
Kidney Int; 2001 Apr; 59(4):1567-73. PubMed ID: 11260422
[TBL] [Abstract][Full Text] [Related]
23. Current immunosuppressive agents in pediatric renal transplantation: efficacy, side-effects and utilization.
Smith JM; Nemeth TL; McDonald RA
Pediatr Transplant; 2004 Oct; 8(5):445-53. PubMed ID: 15367279
[TBL] [Abstract][Full Text] [Related]
24. Prevention of corneal allograft rejection in a mouse model of high risk recipients.
Vítová A; Filipec M; Zajícová A; Krulová M; Holán V
Br J Ophthalmol; 2004 Oct; 88(10):1338-42. PubMed ID: 15377562
[TBL] [Abstract][Full Text] [Related]
25. Strategies in immunosuppression after heart transplantation: is less better?
Kobashigawa JA
Circ Heart Fail; 2011 Mar; 4(2):111-3. PubMed ID: 21406677
[No Abstract] [Full Text] [Related]
26. Systemic immunosuppression with mycophenolate mofetil to prevent corneal graft rejection after high-risk penetrating keratoplasty: a 2-year follow-up study.
Szaflik JP; Major J; Izdebska J; Lao M; Szaflik J
Graefes Arch Clin Exp Ophthalmol; 2016 Feb; 254(2):307-14. PubMed ID: 26553197
[TBL] [Abstract][Full Text] [Related]
27. mTOR inhibitor versus mycophenolic acid as the primary immunosuppression regime combined with calcineurin inhibitor for kidney transplant recipients: a meta-analysis.
Xie X; Jiang Y; Lai X; Xiang S; Shou Z; Chen J
BMC Nephrol; 2015 Jul; 16():91. PubMed ID: 26126806
[TBL] [Abstract][Full Text] [Related]
28. [Toward an evidence-based immunosuppression].
Pascual J
Nefrologia; 2001; 21(6):524-5; discussion 526-7. PubMed ID: 11881421
[No Abstract] [Full Text] [Related]
29. Clear graft survival and immune reactions following emergency keratoplasty.
Maier P; Böhringer D; Reinhard T
Graefes Arch Clin Exp Ophthalmol; 2007 Mar; 245(3):351-9. PubMed ID: 17024439
[TBL] [Abstract][Full Text] [Related]
30. Corticosteroids and kidney transplantation.
Curtis J
Clin J Am Soc Nephrol; 2006 Sep; 1(5):907-8. PubMed ID: 17699305
[No Abstract] [Full Text] [Related]
31. Switching immunosuppression medications after renal transplantation--a common practice.
Meier-Kriesche HU; Chu AH; David KM; Chi-Burris K; Steffen BJ
Nephrol Dial Transplant; 2006 Aug; 21(8):2256-62. PubMed ID: 16574677
[TBL] [Abstract][Full Text] [Related]
32. Sirolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma.
Zimmerman MA; Trotter JF; Wachs M; Bak T; Campsen J; Skibba A; Kam I
Liver Transpl; 2008 May; 14(5):633-8. PubMed ID: 18324656
[TBL] [Abstract][Full Text] [Related]
33. Long-Term Outcomes of High-Risk Keratoplasty in Patients Receiving Systemic Immunosuppression.
Chow SP; Cook SD; Tole DM
Cornea; 2015 Nov; 34(11):1395-9. PubMed ID: 26382894
[TBL] [Abstract][Full Text] [Related]
34. [Monitoring and adjustment of immunosuppression after heart transplantation].
Yerly P; Mach F; Kalangos A; Rotman S; von Segesser L; Vogt P; Hullin R; Pascual M
Rev Med Suisse; 2009 May; 5(205):1214-6, 1218-20. PubMed ID: 19517754
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of systemic tacrolimus in high-risk penetrating keratoplasty after graft failure with systemic cyclosporine.
Yamazoe K; Yamazoe K; Yamaguchi T; Omoto M; Shimazaki J
Cornea; 2014 Nov; 33(11):1157-63. PubMed ID: 25255133
[TBL] [Abstract][Full Text] [Related]
36. Preliminary study of the effect of FK506 nanospheric-suspension eye drops on rejection of penetrating keratoplasty.
Fei WL; Chen JQ; Yuan J; Quan DP; Zhou SY
J Ocul Pharmacol Ther; 2008 Apr; 24(2):235-44. PubMed ID: 18321198
[TBL] [Abstract][Full Text] [Related]
37. Comparing an early corticosteroid/late calcineurin-free immunosuppression protocol to a sirolimus-, cyclosporine A-, and prednisone-based regimen for pancreas-kidney transplantation.
Knight RJ; Podder H; Kerman RH; Lawless A; Katz SM; Van Buren CT; Gaber AO; Kahan BD
Transplantation; 2010 Mar; 89(6):727-32. PubMed ID: 20195219
[TBL] [Abstract][Full Text] [Related]
38. [Systemic therapy of atopic dermatitis].
Heratizadeh A; Breuer K; Kapp A; Werfel T
Hautarzt; 2003 Oct; 54(10):937-45. PubMed ID: 14513240
[TBL] [Abstract][Full Text] [Related]
39. A randomized trial with steroids and antithymocyte globulins comparing cyclosporine/azathioprine versus tacrolimus/mycophenolate mofetil (CATM2) in renal transplantation.
Vacher-Coponat H; Moal V; Indreies M; Purgus R; Loundou A; Burtey S; Brunet P; Moussi-Frances J; Daniel L; Dussol B; Berland Y
Transplantation; 2012 Feb; 93(4):437-43. PubMed ID: 22228415
[TBL] [Abstract][Full Text] [Related]
40. Immunosuppression: towards a logical approach in liver transplantation.
Perry I; Neuberger J
Clin Exp Immunol; 2005 Jan; 139(1):2-10. PubMed ID: 15606606
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
